| Business Summary | | New
Brunswick
Scientific
Co.
Inc.
designs,
manufactures
and
markets
a
variety
of
equipment
used
in
biotechnology
to
create,
maintain,
measure
and
control
the
physical
and
biochemical
conditions
required
for
the
growth
and
detection
of
microorganisms.
This
equipment
is
used
in
medical,
biological,
chemical
and
environmental
research
and
for
the
commercial
development
of
antibiotics,
proteins,
hormones,
enzymes,
monoclonal
antibodies,
agricultural
products,
fuels,
vitamins,
vaccines
and
other
substances.
The
equipment
sold
by
the
Company
includes
fermentation
equipment,
bioreactors,
biological
shakers,
nutrient
sterilizing
and
dispensing
equipment,
ultra-low-temperature
freezers
and
tissue
culture
apparatus. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | NBSC
designs,
manufactures
and
markets
equipment
used
in
biotechnology
to
create,
maintain,
measure
and
control
conditions
required
for
the
growth
and
detection
of
micro-organisms.
For
the
three
months
ended
3/31/01,
net
sales
rose
39%
to
$14.7
million.
Net
income
totaled
$114
thousand
vs.
a
loss
of
$1.4
million.
Revenues
reflect
higher
shipments
of
ultra-low
temperature
freezers.
Net
income
reflects
decreased
R&D
expenses
due
to
a
reduction
in
engineering
costs. Recent Earnings Announcement For
the
3
months
ended
06/30/2001,
revenues
were
14,799;
after
tax
earnings
were
138. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| David Freedman, 80 Chairman,
CEO | $252K | -- | James Orcutt, 43 Pres
of Life Sciences Division | -- | -- | Samuel Eichenbaum, 61 VP
of Fin. and CFO | 148K | $107K | Lee Eppstein, 58 VP,
Technology | 120K | 105K | Sigmund Freedman, 84 Treasurer | 101K | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|